The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis
Open accessAbstract
Objective To evaluate the efficacy and safety of cyproterone acetate versus an oral contraceptive in the treatment of endometriosis-associated recurrent pelvic pain.Design Randomized controlled trial.Setting Academic center.Patient(s) Ninety women with recurrent moderate or severe pelvic pain after conservative surgery for symptomatic endometriosis.Intervention(s) Six months of continuous treatment with oral cyproterone acetate, 12.5 mg/d, or an oral contraceptive containing ethinyl estradiol, 0.02 mg, and desogestrel, 0.15 mg.Main outcome measure(s) Degree of satisfaction with therapy.Result(s) Six patients in the cyproterone acetate arm and nine in the oral contraceptive arm withdrew because of side effects (n = 9), treatment inefficacy (n = 4), or loss to follow-up (n = 2). At 6 months, dysmenorrhea, deep dyspareunia, and nonmenstrual pelvic pain scores were substantially reduced, and significant improvements were observed in health-related quality-of-life, psychiatric profile, and sexual satisfaction; no major between-group differences were seen. Subjective and metabolic side effects were limited. According to an intention-to-treat analysis, 33 of 45 (73%) of patients in the cyproterone acetate group and 30 of 45 (67%) in the oral contraceptive group were satisfied with the treatment received.Conclusions Both cyproterone acetate and a continuous monophasic oral contraceptive were effective, safe, and inexpensive therapy for recurrent pain after conservative surgery for endometriosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, COCs after previous surgery has similar [258] or less efficacy in pain relief than GnRH-a [259].”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [258]
In the citing paper
“Both treatments were equally effective in reducing pain symptoms and enhancing QoL and sexual satisfaction.”
From Oral and depot progestin therapy for endometriosis: towards a personalized medicine (2017) · cites this paper as [47]
In the citing paper
“Overall, at the end of treatment, 73% of the women in the cyproterone acetate group were satisfied or very satisfied compared with 67% in the COC group.”
From Oral and depot progestin therapy for endometriosis: towards a personalized medicine (2017) · cites this paper as [47]
In the citing paper
“Progestins were positively associated with HRQoL in women with endometriosis [20,21,23-25,27,29,30].”
From Health-related quality of life in women with endometriosis: a systematic review (2012) · cites this paper as [21]
In the citing paper
“Continuous therapy with OCs was reported to be as effective as progestins therapy in improving HRQoL, psycho-emotional status and sexual function [21].”
From Health-related quality of life in women with endometriosis: a systematic review (2012) · cites this paper as [21]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
MCHORNEY, C. A., JOHNE, W., & ANASTASIAE, R. (1993) · Medical Care · doi:10.1097/00005650-199303000-00006 · Cited by 6,681
Revised American Fertility Society Classification of Endometriosis: 1985
(1985) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48430-x · Cited by 1,803
The Italian SF-36 Health Survey
Apolone, G., & Mosconi, P. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00094-8 · Cited by 1,148
Self-citationVercellini, P., Trespidi, L., Colombo, A., Vendola, N., Marchini, M., & Crosignani, P. G. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56039-7 · Cited by 311
Self-citationGoldfarb, A. F. (1970) · Fertility and Sterility · doi:10.1016/s0015-0282(16)37275-2 · Cited by 279
Hormone withdrawal symptoms in oral contraceptive users
Sulak, P. (2000) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(99)00524-4 · Cited by 274
Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness
Biberoglu, K. O., & Behrman, S. J. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90478-6 · Cited by 267
Research works printed but not linked: 2
- The American College of Obstetricians and Gynecologists. Medical management of endometriosis. ACOG practice bulletin no. 11. Washington: ACOG Publications, December 1999.
- Royal College of Obstetricians and Gynaecologists. The investigation and management of endometriosis. Guideline no. 24. London: RCOG Press, June 2000.
Cited by
ESHRE guideline: endometriosis
Becker, C. M., Bokor, A., Heikinheimo, O., Horne, A., Jansen, F., Kiesel, L., King, K., Kvaskoff, M., Nap, A., Petersen, K., et al. (2022) · Human Reproduction Open · doi:10.1093/hropen/hoac009 · Cited by 1,712
“Any hormone treatment or surgery can be offered to treat recurring pain symptoms in women with endometriosis (Candiani et al. , 1991; Hornstein et al. , 1997; Vercellini et al. , 2002; Razzi et al. , 2007; Muzii et al. , 2015; Abdou et al. , 2018; Koshiba et al. , 2018; Lee et al. , 2018).”
Systematic review of endometriosis pain assessment: how to choose a scale?
Bourdel, N., Alves, J., Pickering, G., Ramilo, I., Roman, H., & Canis, M. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmu046 · Cited by 372
“5) are enrolled in studies (Vercellini et al., 2002), but these values have not been justified and are derived from expert/consensual guidelines.”
BackgroundHormonal treatments for endometriosis: The endocrine background
Vannuccini, S., Clemenza, S., Rossi, M., & Petraglia, F. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09666-w · Cited by 336
RETIRED: No. 345-Primary Dysmenorrhea Consensus Guideline
Burnett, M., & Lemyre, M. (2017) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2016.12.023 · Cited by 332
Primary Dysmenorrhea Consensus Guideline
(2005) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)30395-4 · Cited by 285
Metadata
- Authors
- Vercellini, P., De Giorgi, O., Mosconi, P., Stellato, G., Vicentini, S., & Crosignani, P. G.
- Affiliations
- University of Milan (IT)
- Mario Negri Institute for Pharmacological Research (IT)
- Corresponding author
- Vercellini, Paolo
- Venue
- Fertility and Sterility
- Publisher
- Elsevier BV
- Published
- 2002-01
- Volume
- 77
- Issue
- 1
- Pages
- 52-61
- ISSN
- 0015-0282 (ISSN-L)
- OpenAlex
- W2151301625
- Cited by
- 180
- References
- 25
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 8 · 2023: 5 · 2022: 9 · 2021: 6 · 2020: 5 · 2019: 2 · 2018: 13 · 2017: 9 · 2016: 6 · 2015: 9 · 2014: 6 · 2013: 6 · 2012: 7
- FWCI
- 9.14
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 7451 d)
- Locations
- Fertility and Sterility (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Keywords
- cyproterone acetate, oral contraceptives, endometriosis, conservative surgery, dysmenorrhea, deep dyspareunia, health-related quality of life, sexual satisfaction, treatment satisfaction, desogestrel, ethinyl estradiol, adverse effects
- MeSH terms
- Adult, Contraceptives, Oral, Depression, Dysmenorrhea, Dyspareunia, Endometriosis, Female, Follow-Up Studies, Humans, Pain, Pain Measurement, Parity, Surveys and Questionnaires, Recurrence, Time Factors, Cyproterone Acetate, Patient Selection, Progesterone Congeners
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis. https://app.cochat.ai/papers/10.1016/s0015-0282(01)02951-x
- The paper
- Vercellini, P., De Giorgi, O., Mosconi, P., Stellato, G., Vicentini, S., & Crosignani, P. G. (2002). Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis. Fertility and Sterility. https://doi.org/10.1016/s0015-0282(01)02951-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.